Please use this identifier to cite or link to this item:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/33433
Full metadata record
???org.dspace.app.webui.jsptag.ItemTag.dcfield??? | Value | Language |
---|---|---|
dc.contributor.advisor | 林峰輝(Feng-Huei Lin) | |
dc.contributor.author | Tzu-Wei Wang | en |
dc.contributor.author | 王子威 | zh_TW |
dc.date.accessioned | 2021-06-13T04:40:15Z | - |
dc.date.available | 2006-07-20 | |
dc.date.copyright | 2006-07-20 | |
dc.date.issued | 2006 | |
dc.date.submitted | 2006-07-18 | |
dc.identifier.citation | [1] Yannas, I.V. Tissue and organ regeneration in adults. New York: Springer; 2001
[2] Lee SB. Jeon HW. Lee YW. Lee YM. Song KW. Park MH. Nam YS. Ahn HC. Bio-artificial skin composed of gelatin and (1-->3), (1-->6)-beta-glucan. Biomaterials. 24(14):2503-11, 2003 [3] Usta M. Piech DL. MacCrone RK. Hillig WB. Behavior and properties of neat and filled gelatins. Biomaterials. 24(1):165-72, 2003 [4] Ponticiello MS. Schinagl RM. Kadiyala S. Barry FP. Gelatin-based resorbable sponge as a carrier matrix for human mesenchymal stem cells in cartilage regeneration therapy. Journal of Biomedical Materials Research. 52(2):246-55, 2000 [5] Chen YS. Chang JY. Cheng CY. Tsai FJ. Yao CH. Liu BS. An in vivo evaluation of a biodegradable genipin-cross-linked gelatin peripheral nerve guide conduit material. Biomaterials. 26(18):3911-8, 2005 [6] Noorjahan SE. Sastry TP. An in vivo study of hydrogels based on physiologically clotted fibrin-gelatin composites as wound-dressing materials. Journal of Biomedical Materials Research. 71(2):305-12, 2004 [7] Balakrishnan B. Mohanty M. Umashankar PR. Jayakrishnan A. Evaluation of an in situ forming hydrogel wound dressing based on oxidized alginate and gelatin. Biomaterials. 26(32):6335-42, 2005 [8] Matsuda K. Suzuki S. Isshiki N. Yoshioka K. Okada T. Ikada Y. Influence of glycosaminoglycans on the collagen sponge component of a bilayer artificial skin. Biomaterials. 11(5):351-5, 1990 [9] Tomihata K. Ikada Y. Crosslinking of hyaluronic acid with water-soluble carbodiimide. Journal of Biomedical Materials Research. 37(2):243-51, 1997 [10] Aruffo A. Stamenkovic I. Melnick M. Underhill CB. Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell. 61(7):1303-13, 1990 [11] Hall CL. Wang C. Lange LA. Turley EA. Hyaluronan and the hyaluronan receptor RHAMM promote focal adhesion turnover and transient tyrosine kinase activity. Journal of Cell Biology. 126(2):575-88, 1994 [12] Boyce ST. Christianson DJ. Hansbrough JF. Structure of a collagen-GAG dermal skin substitute optimized for cultured human epidermal keratinocytes. Journal of Biomedical Materials Research. 22(10):939-57, 1988 [13] Yannas IV. Burke JF. Gordon PL. Huang C. Rubenstein RH. Design of an artificial skin. II. Control of chemical composition. Journal of Biomedical Materials Research. 14(2):107-32, 1980 [14] Pieper JS. Oosterhof A. Dijkstra PJ. Veerkamp JH. van Kuppevelt TH. Preparation and characterization of porous crosslinked collagenous matrices containing bioavailable chondroitin sulfate. Biomaterials. 20(9):847-58, 1999 [15] Olde Damink LH. Dijkstra PJ. van Luyn MJ. van Wachem PB. Nieuwenhuis P. Feijen J. Cross-linking of dermal sheep collagen using a water-soluble carbodiimide. Biomaterials. 17(8):765-73, 1996 [16] Inoue S. Ultrastructure of basement membranes. International Review of Cytology. 117:57-98,1989 [17] Amano S. Akutsu N. Matsunaga Y. Nishiyama T. Champliaud MF. Burgeson RE. Adachi E. Importance of balance between extracellular matrix synthesis and degradation in basement membrane formation. Experimental Cell Research. 271(2):249-262, 2001 [18] Burgeson RE. Christiano AM. The dermal-epidermal junction. Current Opinion in Cell Biology. 9(5):651-658, 1997 [19] Marinkovich MP. Keene DR. Rimberg CS. Burgeson RE. Cellular origin of the dermal-epidermal basement membrane. Developmental Dynamics. 197(4):255-267, 1993 [20] Adams JC. Watt FM. Expression of beta 1, beta 3, beta 4, and beta 5 integrins by human epidermal keratinocytes and non-differentiating keratinocytes. Journal of Cell Biology. 115(3):829-41, 1991 [21] Mercurio AM. Rabinovitz I. Shaw LM. The alpha 6 beta 4 integrin and epithelial cell migration. Current Opinion in Cell Biology. 13(5):541-5, 2001 [22] Hertle MD. Adams JC. Watt FM. Integrin expression during human epidermal development in vivo and in vitro. Development. 112(1):193-206, 1991 [23] Niessen CM. Hogervorst F. Jaspars LH. de Melker AA. Delwel GO. Hulsman EH. Kuikman I. Sonnenberg A. The alpha 6 beta 4 integrin is a receptor for both laminin and kalinin. Experimental Cell Research. 211(2):360-7, 1994 [24] Tsunenaga M. Adachi E. Amano S. Burgeson RE. Nishiyama T. Laminin 5 can promote assembly of the lamina densa in the skin equivalent model. Matrix Biology. 17(8-9):603-13, 1998 [25] Nishiyama T. Amano S. Tsunenaga M. Kadoya K. Takeda A. Adachi E. Burgeson RE. The importance of laminin 5 in the dermal-epidermal basement membrane. Journal of Dermatological Science. 24 Suppl 1:S51-9, 2000 [26] Konig A. Bruckner-Tuderman L. Epithelial-mesenchymal interactions enhance expression of collagen VII in vitro. Journal of Investigative Dermatology. 96(6):803-8, 1991 [27] Huber M. Scaletta C. Benathan M. Frenk E. Greenhalgh DA. Rothnagel JA. Roop DR. Hohl D. Abnormal keratin 1 and 10 cytoskeleton in cultured keratinocytes from epidermolytic hyperkeratosis caused by keratin 10 mutations. Journal of Investigative Dermatology. 102(5):691-4, 1994 [28] Young P. Boussadia O. Halfter H. Grose R. Berger P. Leone DP. Robenek H. Charnay P. Kemler R. Suter U. E-cadherin controls adherens junctions in the epidermis and the renewal of hair follicles. The EMBO Journal. 22(21):5723-33, 2003 [29] Ivarsson M. McWhirter A. Borg TK. Rubin K. Type I collagen synthesis in cultured human fibroblasts: regulation by cell spreading, platelet-derived growth factor and interactions with collagen fibers. Matrix Biology. 16(7):409-25, 1998 [30] Christiano AM. Uitto J. Molecular complexity of the cutaneous basement membrane zone. Revelations from the paradigms of epidermolysis bullosa. Experimental Dermatology. 5:1-11, 1996 [31] Spirito F. Chavanas S. Prost-Squarcioni C. Pulkkinen L. Fraitag S. Bodemer C. Ortonne JP. Meneguzzi G. Reduced expression of the epithelial adhesion ligand laminin 5 in the skin causes intradermal tissue separation. The Journal of Biological Chemistry. 276(22):18828-18835, 2001 [32] Funderburgh JL, Mann MM, Funderburgh ML. Keratocyte phenotype mediates proteoglycan structure: a role for fibroblasts in corneal fibrosis. The Journal of Biological Chemistry. 278(46):45629-45637, 2003 [33] Nievers MG, Schaapveld RQ, Sonnenberg A. Biology and function of hemidesmosomes. Matrix Biology. 18(1):5-17, 1999 [34] Loss M, Wedler V, Kunzi W, Meuli-Simmen C, Meyer VE. Artificial skin, split-thickness autograft and cultured autologous keratinocytes combined to treat a severe burn injury of 93% of TBSA. Burns. 26(7):644-652, 2000 [35] Robson MC, Barnett RA, Leitch IO, Hayward PG. Prevention and treatment of postburn scars and contracture. World Journal of Surgery. 16(1):87-96, 1992 [36] Heck EL, Bergstresser PR, Baxtor CR. Composite skin graft: Frozen dermal allografts support the engraftment and expansion of autologous epidermis. The Journal of Trauma. 25(2):106–112, 1985 [37] Burke JF, Yannas IV, Quinby WC Jr, Bondoc CC, Jung WK. Successful use of a physiologically acceptable artificial skin in the treatment of extensive burn injury. Annals of Surgery. 194(4):413–428, 1981 [38] Bell E, Sher S, Hull B, Merrill C, Rosen S, Chamson A, Asselineau D, Dubertret L, Coulomb B, Lapiere C, Nusgens B, Neveux Y. The reconstitution of living skin. The Journal of Investigative Dermatology. 81(1 Suppl):2S–10S, 1983 [39] Peeters R, De Caluwe D, Neetens C. Use of glycerolized cadaver skin for the treatment of scalds in children. Burns. 20:32–33, 1994 [40] Spence RJ, Wong L. The enhancement of wound healing with human skin allograft. The Surgical Clinics of North America. 77:731–45, 1997 [41] Greeleaf G, Hansbrough JF. Current trends in the use of allograft skin for patients with burns and reflections on the future of skin banking in the United States. The Journal of Burn Care & Rehabilitation. 15:428–31, 1994 [42] Kremer M, Lang E, Berger AC. Evaluation of dermal-epidermal skin equivalents (“composite-skin”) of human keratinocytes in a collagen-glycosaminoglycan matrix (Integra Artificial Skin). British Journal of Plastic Surgery. 53:459–65, 2000 [43] Medalie DA, Eming DA, TompKins RG, Yarmush ML, Krueger GG, Morgan JR. Evaluation of human skin reconstituted from composite grafts of cultured keratinocytes and human acellular dermis transplanted to athymic mice. The Journal of Investigative Dermatology. 107:121–7, 1996 [44] Black AF, Berthod F, L’Heureux N, Germain L, Auger FA. In vitro reconstruction of a human capillary-like network in a tissue-engineered skin equivalent. The FASEB Journal. 12(13):1331-1340, 1998 [45] Rheinwald JG, Green H. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell. 6:331–44, 1975 [46] Rheinwald JG, Green H. Epidermal growth factor and the multiplication of cultured human epidermal keratinocytes. Nature. 265:421–4, 1977 [47] Green H, Kehinde O, Thomas J. Growth of cultured human epidermal cells into multiple epithelia suitable for grafting. Proceedings of the National Academy of Sciences of the United States of America. 76:5665–8, 1979 [48] Woodley DT, Peterson HD, Herzog SR, et al. Burn wounds resurfaced by cultured epidermal autografts show abnormal reconstitution of anchoring fibrils. JAMA. 259:2566–71, 1988 [49] Butler CE, Yannas IV, Compton CC, Correia CA, Orgill DP. Comparison of cultured and uncultured keratinocytes seeded into a collagen-GAG matrix for skin replacements. British Journal of Plastic Surgery. 52:127–32, 1999 [50] Bell E, Ehrlich HP, Buttle DJ, Nakatsuji T. Living tissue formed in vitro and accepted as skin-equivalent tissue of full thickness. Science. 211(4486): 1052-1054, 1981 [51] Naughton G, Mansbridge J, Gentzkow G. A metabolically active human dermal replacement for the treatment of diabetic foot ulcers. Artificial Organs. 21(11): 1203-1210, 1997 [52] Orgill DP, Butler C, Regan JF, Barlow MS, Yannas IV, Compton CC. Vascularized collagen-glycosaminoglycan matrix provides a dermal substrate and improves take of cultured epithelial autografts. Plastic and Reconstructive Surgery. 102(2):423-429, 1998 [53] Pandit A, Ashar R, Feldman D, Thompson A. Investigation of acidic fibroblast growth factor delivered through a collagen scaffold for the treatment of full-thickness skin defects in a rabbit model. Plastic and Reconstructive Surgery. 101(3):766-775, 1998 [54] Srivastava A, DeSagun EZ. Jennings LJ, Sethi S, Phuangsab A, Hanumadass M, Reyes HM, Walter RJ. Use of porcine acellular dermal matrix as a dermal substitute in rats. Annals of Surgery. 233(3):400-408, 2001 [55] Bello YM, Falabella AF, Eaglstein WH. Tissue-engineered skin. Current status in wound healing. American Journal of Clinical Dermatology. 2(5):305-313, 2001 [56] Gentzkow GD, Iwasaki SD, Hershon KS, Mengel M, Prendergast JJ, Ricotta JJ, Steed DP, Lipkin S. Use of dermagraft, a cultured human dermis, to treat diabetic foot ulcers. Diabetes Care. 19(4):350-354, 1996 [57] Noordenbos J, Dore C, Hansbrough JF. Safety and efficacy of TransCyte for the treatment of partial-thickness burns. The Journal of Burn Care & Rehabilitation. 20(4):275-281, 1999 [58] Wainwright DJ. Use of an acellular allograft dermal matrix (AlloDerm) in the management of full-thickness burns. Burns. 21(4):243-248, 1995 [59] Kremer M, Lang E, Berger AC. Evaluation of dermal-epidermal skin equivalents ('composite-skin') of human keratinocytes in a collagen-glycosaminoglycan matrix(Integra artificial skin). British Journal of Plastic Surgery. 53(6):459-465, 2000 [60] Guerret S, Govignon E, Hartmann DJ, Ronfard V. Long-term remodeling of a bilayered living human skin equivalent (Apligraf) grafted onto nude mice: immunolocalization of human cells and characterization of extracellular matrix. Wound Repair and Regeneration. 11(1):35-45, 2003 [61] Young, B., Lowe, J.S., Stevens, A., Heath, J.W. Wheater's Functional Histology, 5th edition. Edinburgh: Churchill Livingstone; 2006 [62] Uitto, J.A. The dermal epidermal basement membrane zone in cutaneous wound healing. In The Molecular and cellular Biology of Wound Repair, edited by Clark, R.A.F. New York : Plenum Press; 1996 [63] Farquhar, M.G. The glomerular basement membrane: a selective macromolecular filter. In Cell Biology of Extracellular Matrix, edited by Hay, E.D. New York: Plenum Press, pp. 335-378, 1981 [64] Furthmayr, H. Basement membranes. In The Molecular and cellular Biology of Wound Repair, edited by Clark, R.A.F. New York : Plenum Press; 1996 [65] Burgeson RE. Christiano AM. The dermal-epidermal junction. Current Opinion in Cell Biology. 9(5):651-8, 1997 [66] Karelina TV. Bannikov GA. Eisen AZ. Basement membrane zone remodeling during appendageal development in human fetal skin. The absence of type VII collagen is associated with gelatinase-A (MMP2) activity. Journal of Investigative Dermatology. 114(2):371-5, 2000 [67] Carver N. Navsaria HA. Fryer P. Green CJ. Leigh IM. Restoration of basement membrane structure in pigs following keratinocyte autografting. British Journal of Plastic Surgery. 46(5):384-92, 1993 [68] Rigal C. Pieraggi MT. Vincent C. Prost C. Bouisou H. Serre G. Healing of full-thickness cutaneous wounds in the pig. I. Immunohistochemical study of epidermo-dermal junction regeneration. Journal of Investigative Dermatology. 96(5):777-85, 1991 [69] Monafo WW. Initial management of burns. New England Journal of Medicine. 335(21):1581-6, 1996 [70] Chien WC. Pai L. Lin CC. Chen HC. Epidemiology of hospitalized burns patients in Taiwan. Burns. 29(6):582-8, 2003 [71] Church D, Elsayed S, Reid O, Winston B, Lindsay R. Burn Wound Infections. Clinical Microbiology Reviews. 19(2):403–434, 2006 [72] Singer AJ. Clark RA. Cutaneous wound healing. New England Journal of Medicine. 341(10):738-46, 1999 [73] Clark, R.A.F. The Molecular and cellular Biology of Wound Repair. New York : Plenum Press; 1996 [74] Lin SD. Lai CS. Chou CK. Tsai CW. Wu KF. Chang CW. Microskin autograft with pigskin xenograft overlay: a preliminary report of studies on patients. Burns. 18(4):321-5, 1992 [75] Basile AR. A comparative study of glycerinized and lyophilized porcine skin in dressings for third-degree burns. Plastic & Reconstructive Surgery. 69(6):969-74, 1982 [76] Pruitt BA Jr. The evolutionary development of biologic dressings and skin substitutes. Journal of Burn Care & Rehabilitation. 18(1 Pt 2):S2-5, 1997 [77] Compton CC. Hickerson W. Nadire K. Press W. Acceleration of skin regeneration from cultured epithelial autografts by transplantation to homograft dermis. Journal of Burn Care & Rehabilitation. 14(6):653-62, 1993 [78] Abbott WM. Hembree JS. Absence of antigenicity in freeze-dried skin allografts. Cryobiology. 6(5):416-8, 1970 [79] Schechter I. Prolonged retention of glutaraldehyde-treated skin allografts and xenografts: immunological and histological studies. Annals of Surgery. 182(6):699-704, 1975 [80] Hussmann J. Russell RC. Kucan JO. Hebebrand D. Bradley T. Steinau HU. Use of glycerolized human allografts as temporary (and permanent) cover in adults and children. Burns. 20 Suppl 1:S61-5; discussion S65-6, 1994 [81] Peeters R. De Caluwe D. Neetens C. Hubens A. Use of glycerolized cadaver skin for the treatment of scalds in children. Burns. 20 Suppl 1:S32-3, 1994 [82] Salisbury RB. Use of the mesh skin graft in treatment of massive casualty wounds. Plastic & Reconstructive Surgery. 40(2):161-2, 1967 [83] Ruszczak Z. Schwartz RA. Modern aspects of wound healing: An update. Dermatologic Surgery. 26(3):219-29, 2000 [84] Bello YM. Falabella AF. Eaglstein WH. Tissue-engineered skin. Current status in wound healing. American Journal of Clinical Dermatology. 2(5):305-13, 2001 [85] Sefton MV. Woodhouse KA. Tissue engineering. Journal of Cutaneous Medicine & Surgery. 3 Suppl 1:S1-18-23, 1998 [86] Burke JF. Yannas IV. Quinby WC Jr. Bondoc CC. Jung WK. Successful use of a physiologically acceptable artificial skin in the treatment of extensive burn injury. Annals of Surgery. 194(4):413-28, 1981 [87] Ramos-e-Silva M. Ribeiro de Castro MC. New dressings, including tissue-engineered living skin. Clinics in Dermatology. 20(6):715-23, 2002 [88] Wound Healing: Tissue Engineered Skin Substitutes and Growth Factors. Cigna Healthcare Cover Position; 2006 [89] Mooney D. Chapter 6: Engineering Design Aspects of Tissue Engineering. In WTEC Panel Report on Tissue Engineering Research. International Technology Research Institute World Technology (WTEC) Division. pp.59-67; 2002 [90] Schulz JT 3rd. Tompkins RG. Burke JF. Artificial skin. Annual Review of Medicine. 51:231-44, 2000 [91] Bansil R. Yannas IV. Stanley HE. Raman spectroscopy: a structural probe of glycosaminoglycans. Biochimica et Biophysica Acta. 541(4):535-42, 1978 [92] Choi YS. Hong SR. Lee YM. Song KW. Park MH. Nam YS. Studies on gelatin-containing artificial skin: II. Preparation and characterization of cross-linked gelatin-hyaluronate sponge. Journal of Biomedical Materials Research. 48(5):631-9, 1999 [93] Swann DA. Balazes EZ. Determination of the hexosamine content of macromolecules with manual and automated techniques using the p-dimethylaminobenzaldehyde reaction. Biochimica et Biophysica Acta. 130: 112-129, 1966 [94] Yannas IV. Burke JF. Gordon PL. Huang C. Rubenstein RH. Design of an artificial skin. II. Control of chemical composition. Journal of Biomedical Materials Research. 14(2):107-32, 1980 [95] Kakade ML. Liener IE. Determination of available lysine in proteins. Analytical Biochemistry. 27(2):273-80, 1969 [96] Sashidhar RB. Capoor AK. Ramana D. Quantitation of epsilon-amino group using amino acids as reference standards by trinitrobenzene sulfonic acid. A simple spectrophotometric method for the estimation of hapten to carrier protein ratio. Journal of Immunological Methods. 167(1-2):121-7, 1994 [97] Bubnis WA. Ofner CM 3rd. The determination of epsilon-amino groups in soluble and poorly soluble proteinaceous materials by a spectrophotometric method using trinitrobenzenesulfonic acid. Analytical Biochemistry. 207(1):129-33, 1992 [98] Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assay. Journal of Immunological Methods. 65:55–63. 1983 [99] Korzeniewski C. Callewaert DM. An enzyme-release assay for natural cytotoxicity. Journal of Immunological Methods. 64:313-20, 1983 [100] Wang TW. Wu HC. Huang YC. Sun JS. Lin FH. Biomimetic bilayered gelatin-chondroitin 6 sulfate-hyaluronic acid biopolymer as the scaffold for skin equivalent tissue engineering. Artificial Organs. 30(3):141–149, 2006 [101] Yang A. Schweitzer R. Sun D. Kaghad M. Walker N. Bronson RT. Tabin C. Sharpe A. Caput D. Crum C. McKeon F. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature. 398(6729):714-8, 1999 [102] Germain L. Guignard R. Rouabhia M. Auger FA. Early basement membrane formation following the grafting of cultured epidermal sheets detached with thermolysin or dispase. Burns. 21(3):175-180, 1995 [103] Pieper JS. van Wachem PB. van Luyn MJA. Brouwer LA. Hafmans T. Veerkamp JH. van Kuppevelt TH. Attachment of glycosaminoglycans to collagenous matrices modulates the tissue response in rats. Biomaterials. 21(16):1689-99, 2000 [104] Jackson RL. Busch SJ. Cardin AD. Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes. Physiological Reviews. 71(2):481-539, 1991 [105] Shafritz TA. Rosenberg LC. Yannas IV. Specific effects of glycosaminoglycans in an analog of extracellular matrix that delays wound contraction and induces regeneration. Wound Repair and Regeneration. 2(4): 270-276, 1994 [106] Chan L. Wong YC. Cytochemical localization and characterization of proteoglycans (glycosaminoglycans) in the epithelial– stromal interface of the seminal vesicle of the guinea pig. Journal of Anatomy. 180:41–56, 1992 [107] Willen MD. Sorrell JM. Lekan CC. Davis BR. Caplan AI. Patterns of glycosaminoglycan/proteoglycan immunostaining in human skin during aging. Journal of Investigative Dermatology. 96(6):968-74, 1991 [108] Hanthamrongwit M. Reid WH. Grant MH. Chondroitin-6-sulfate incorporated into collagen gels for the growth of human keratinocytes: the effect of cross-linking agents and diamines. Biomaterials. 17(8):775-80, 1996 [109] Slevin M. Kumar S. Gaffney J. Angiogenic oligosaccharides of hyaluronan induce multiple signaling pathways affecting vascular endothelial cell mitogenic and wound healing responses. Journal of Biological Chemistry. 277(43):41046-59, 2002 [110] Sattar A. Rooney P. Kumar S. Pye D. West DC. Scott I. Ledger P. Application of angiogenic oligosaccharides of hyaluronan increases blood vessel numbers in rat skin. Journal of Investigative Dermatology. 103(4):576-9, 1994 [111] Black AF. Berthod F. L'heureux N. Germain L. Auger FA. In vitro reconstruction of a human capillary-like network in a tissue-engineered skin equivalent. The FASEB Journal. 12(13):1331-40, 1998 [112] van Wachem PB. Plantinga JA. Wissink MJ. Beernink R. Poot AA. Engbers GH. Beugeling T. van Aken WG. Feijen J. van Luyn MJ. In vivo biocompatibility of carbodiimide-crosslinked collagen matrices: Effects of crosslink density, heparin immobilization, and bFGF loading. Journal of Biomedical Materials Research. 55(3):368-78, 2001 [113] O'Brien FJ. Harley BA. Yannas IV. Gibson L. Influence of freezing rate on pore structure in freeze-dried collagen-GAG scaffolds. Biomaterials. 25(6):1077-86, 2004 [114] Tomihata K. Ikada Y. Crosslinking of hyaluronic acid with water-soluble carbodiimide. Journal of Biomedical Materials Research. 37(2):243-51, 1997 [115] Culp LA. Murray BA. Rollins BJ. Fibronectin and proteoglycan as determinants of cell-substratum adhesion. Journal of Supramolecular Structure. 11:401–27, 1979 [116] Hersel U. Dahmen C. Kessler H. RGD modified polymers: biomaterials for stimulated cell adhesion and beyond. Biomaterials 24: 4385–415, 2003 [117] Quirk RA. Chan WC. Davies MC. Tendler SJ. Shakesheff KM. Poly(L-lysine)-GRGDS as a biomimetic surface modifier for poly(lactic acid). Biomaterials. 22(8):865-72, 2001 [118] Phillips JM. Kao WJ. Macrophage adhesion on gelatin-based interpenetrating networks grafted with PEGylated RGD. Tissue Engineering. 11(5-6):964-73, 2005 [119] Schwick HG. Heide K. Immunochemistry and immunology of collagen and gelatin. Bibliotheca Haematologica. 33:111-25, 1969 [120] Krummel TM, Mast BA, Haynes JH, Diegelmann RF, Cohen IK. Characteristics of fetal repair. Progress in Clinical and Biological Research. 365:167–76, 1991 [121] Longaker MT, Adzick NS. The biology and therapeutic applications of fetal wound healing. Clinical Materials. 8:223–7, 1991 [122] Hall CL. Wang C. Lange LA. Turley EA. Hyaluronan and the hyaluronan receptor RHAMM promote focal adhesion turnover and transient tyrosine kinase activity. The Journal of Cell Biology. 126:575–88, 1994 [123] Sterling H. Saginario C. Vignery A. CD44 occupancy prevents macrophage multinucleation. The Journal of Cell Biology. 143:837–47, 1998 [124] Wang HJ. Bertrand-de Hass M. van Blitterswijk CA. Lamme EN. Engineering of a dermal equivalent: seeding and culturing fibroblasts in PEGT/PBT copolymer scaffolds. Tissue Engineering. 9:909–17, 2003 [125] Germain L. Rouabhia M. Guignard R. Carrier L. Bouvard V. Auger FA. Improvement of human keratinocyte isolation and culture using thermolysin. Burns 19:99–104, 1993 [126] Boyce ST. Supp AP. Harriger MD. Greenhalgh DG. Warden GD. Topical nutrients promote engraftment and inhibit wound contraction of cultured skin substitutes in athymic mice. The Journal of Investigative Dermatology. 104:345–9, 1995 [127] Tsuzuki Y. Fukumura D. Oosthuyse B. Koike C. Carmeliet P. Jain RK. Vascular endothelial growth factor (VEGF) modulation by targeting hypoxia-inducible factor-1alpha → hypoxia response element → VEGF cascade differentially regulates vascular response and growth rate in tumors. Cancer Research. 60:6248–52, 2000 [128] Huang YC. Wang TW. Sun JS. Lin FH. Cultured keratinocytes and dermal fibroblasts on a double layer scaffold with bi-medium culture system. Biomedical Sciences Instrumentation. 39:500–5, 2003 [129] Dagalakis N. Flink J. Stasikelis P. Burke JF. Yannas IV. Design of an artificial skin. Part III. Control of pore structure. Journal of Biomedical Materials Research. 14:511–27, 1980 [130] El Ghalbzouri A. Ponec M. Diffusible factors released by fibroblasts support epidermal morphogenesis and deposition of basement membrane components. Wound Repair and Regeneration. 12:359–67, 2004 [131] Coulomb B, Lebreton C, Dubertret L. Influence of human dermal fibroblasts on epidermalization. The Journal of Investigative Dermatology. 92:122–5, 1989 [132] Demarchez M, Hartmann DJ, Regnier M, Asselineau D. The role of fibroblasts in dermal vascularization and remodeling of reconstructed human skin after transplantation onto the nude mouse. Transplantation. 54:317–26, 1992 [133] Bell E, Ehrlich HP, Buttle DJ, Nakatsuji T. Living tissue formed in vitro and accepted as skin-equivalent tissue of full thickness. Science. 211(4486):1052-1054, 1981 [134] Boyce ST, Christianson DJ, Hansbrough JF. Structure of a collagen-GAG dermal skin substitute optimized for cultured human epidermal keratinocytes. Journal of Biomedical Materials Research. 22(10):939-957, 1988 [135] Konig A, Bruckner-Tuderman L. Epithelial-mesenchymal interactions enhance expression of collagen VII in vitro. The Journal of Investigative Dermatology. 96(6):803-808, 1991 [136] Ralston DR, Layton C, Dalley AJ, Boyce SG, Freedlander E, Mac Neil S. The requirement for basement membrane antigens in the production of human epidermal/dermal composites in vitro. The British Journal of Dermatology. 140(4):605-615, 1999 [137] Amano S, Akutsu N, Matsunaga Y, Nishiyama T, Champliaud MF, Burgeson RE, Adachi E. Importance of balance between extracellular matrix synthesis and degradation in basement membrane formation. Experimental Cell Research. 271(2):249-262, 2001 [138] Tsunenaga M, Adachi E, Amano S, Burgeson RE, Nishiyama T. Laminin 5 can promote assembly of the lamina densa in the skin equivalent model. Matrix Biology. 17(8-9):603-613, 1998 [139] Nishiyama T, Amano S, Tsunenaga M, Kadoya K, Takeda A, Adachi E, Burgeson RE. The importance of laminin 5 in the dermal-epidermal basement membrane. Journal of Dermatological Science. 24 Suppl 1:S51-59, 2000 [140] Fusenig NE, Leigh I, Lane B, Watt F. Epithelial-mesenchymal interactions regulate keratinocyte growth and differentiation in vitro. In The Keratinocyte Handbook. Cambridge Univ. Press, Cambridge, UK 71–97, 1994 [141] Fleischmajer R, Utani A, MacDonald ED, Perlish JS, Pan TC, Chu ML, Nomizu M, Ninomiya Y, Yamada Y. Initiation of skin basement membrane formation at the epidermo-dermal interface involves assembly of laminins through binding to cell membrane receptors. Journal of Cell Science. 111(14):1929-1940, 1998 [142] Eckhart L, Reinisch C, Inoue S, Messner P, Dockal M, Mayer C, Tschachler E. A basement membrane-like matrix formed by cell-released proteins at the medium/air interface supports growth of keratinocytes. European Journal of Cell Biology. 82(11):549-555, 2003 [143] Horch RE, Kopp J, Kneser U, Beier J, Bach AD. Tissue engineering of cultured skin substitutes. Journal of Cellular and Molecular Medicine. 9(3):592-608, 2005 [144] Choi YS, Hong SR, Lee YM, Song KW, Park MH, Nam YS. Studies on gelatin-containing artificial skin: II. Preparation and characterization of cross-linked gelatin-hyaluronate sponge. Journal of Biomedical Materials Research. 48(5):631-639, 1999 [145] Huang YC, Wang TW, Sun JS, Lin FH. Epidermal morphogenesis in an in-vitro model using a fibroblasts-embedded collagen scaffold. Journal of Biomedical Science. 12(6):855-867, 2005 [146] Grant I, Green C, Martin R. Strategies to improve the take of commercially available collagen/glycosaminoglycan wound repair material investigated in an animal model. Burns. 27(7):699-707, 2001 [147] Pouliot R, Larouche D, Auger FA, Juhasz J, Xu W, Li H, Germain L. Reconstructed human skin produced in vitro and grafted on athymic mice. Transplantation. 73(11):1751-1757, 2002 [148] Usui ML, Underwood RA, Mansbridge JN, Muffley LA, Carter WG, Olerud JE. Morphological evidence for the role of suprabasal keratinocytes in wound reepithelialization. Wound Repair and Regeneration. 13(5):468-479, 2005 [149] Carrel A, Hartmann A. Cicatrization of wounds I: The regulation between the size of a wound and the rate of its cicatrisation. The Journal of Experimental Medicine. 24: 429-450, 1916 [150] Kangesu T. Navsaria HA. Manek S. Shurey CB. Jones CR. Fryer PR. Leigh IM. Green CJ. A porcine model using skin graft chambers for studies on cultured keratinocytes. British Journal of Plastic Surgery. 46(5):393-400, 1993 [151] Cohen IK. Wound healing models to study connective tissue metabolism: Normal and chronic wounds. In Clinical and Experimental Approaches to Dermal and Epidermal Repair, edited by Barbul AM…etc. New York: Alan R. Liss. [152] Greenhalgh DG. Sprugel KH. Murray MJ. Ross R. PDGF and FGF stimulate wound healing in the genetically diabetic mouse. American Journal of Pathology. 136(6):1235-46, 1990 [153] Puolakkainen PA. Twardzik DR. Ranchalis JE. Pankey SC. Reed MJ. Gombotz WR. The enhancement in wound healing by transforming growth factor-beta 1 (TGF-beta 1) depends on the topical delivery system. Journal of Surgical Research. 58(3):321-9, 1995 [154] Huang YC, Wang TW, Sun JS, Lin FH. The Investigation of MMC-treated Fibroblast in 3-D Collagen Gel and Conditioned Medium for Keratinocyte Proliferation. Artificial Organs. 30(3):150-9, 2006 [155] Huang YC, Wang TW, Sun JS, Lin FH. Effect of Calcium Ion Concentration on Keratinocyte Behaviors in the Defined Media. Biomedical Engineering Applications Basis and Communications. 18:37-41, 2006 [156] Wang TW, Wu HC, Huang YC, Sun JS, Lin FH. The Effect of the Self-designed Bifunctional RGD-containing Fusion Protein on the Behavior of Human Keratiocytes and Dermal Fibroblasts. Journal of Biomedical Materials Research. In press [157] Wang TW, Sun JS, Huang YC, Wu HC, Chen LT, Lin FH. Skin Basement Membrane and Extracellular Matrix Proteins Characterization and Quantification by Real Time RT-PCR. Biomaterials. In press | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/33433 | - |
dc.description.abstract | 本研究的目的是希望以組織工程的方式發展出一個類皮膚的等價物(skin equivalent),來促進皮膚的修復與再生,藉以幫助臨床上大面積燒燙傷以及傷口難以癒合的病人。
首先需發展出一適合的皮膚支架(scaffold),為了模擬皮膚細胞外基質(extracellular matrix)的成分,本研究選用明膠/軟骨硫素/透明質酸 (gelatin-chondroitin 6 sulfate-hyaluronic acid; G-C6S-HA)來當作基材。再利用不同冷凍速率之溫度下冷凍乾燥(freeze-drying)的方式形成具有雙層孔洞結構(bi-layer)的G-C6S-HA薄膜;並進一步利用碳二醯胺(carbodiimide)來交聯,以促進此G-C6S-HA薄膜的機械強度。 第一階段將先評估製備出的G-C6S-HA薄膜其孔洞型態(morphology),物理化學性質(physical-chemical),以及生物相容性(biocompatibility),是否適合作為一皮膚再生的模型。 第二階段是利用此模型評估其在體外(in vitro)建構出皮膚等價物(skin equivalent)的可行性。培養過程中,首先利用本實驗室開發出的攪拌瓶反應器(spinner flask),來種植皮膚真皮纖維母細胞(dermal fibroblast; FB),以達到高種植效率(seeding efficiency),以及細胞均勻分佈(homogeneous cell distribution)的優點;接著再將此種植有真皮纖維母細胞的真皮等價物(dermal equivalent),接種上表皮的角化細胞(epidermal keratinocyte; K),之後將此皮膚等價物在液面下(submerge)培養一段時間,再移到氣液介面下(air-liquid interface)讓皮膚表皮組織成熟分化(epidermalization)。經過三到四週的培養,表皮角化細胞已能從基底層(basal layer)開始往上分化出基底上層(suprabasal layer)和角質層(cornified squamous layer);真皮纖維母細胞同時也開始分泌出自己的細胞外基質來逐漸取代原來的支架位置,並發展出一類似真皮的結構。 第三階段將利用此模型在3D仿器官生長(organotypic culture)的模式下,探討皮膚基底層(basement membrane; BM)與細胞外基質(extracellular matrix; ECM)蛋白的生成與活性表現,並利用組織免疫化學法(immunohistochemistry)與即時定量聚合酵素連鎖反應(real time PCR)來加以定性並定量分析,探討其分泌量上的變化與受何種細胞所調控分泌。研究中發現BM and ECM蛋白的表現是受到表皮細胞與真皮纖維母細胞的精密調控(sophisticated interplay),隨著培養的時間會有所變化,最後達到動態的平衡。 第四階段將種植有人類表皮角化細胞與真皮纖維母細胞(human K&FB)的G-C6S-HA皮膚替代物(skin substitute),移植到免疫不全(severe combined immunodeficiency; SCID)的老鼠背部,評估其促進傷口修復(wound healing)的能力。結果顯示,在移植四週後,新長出來的皮膚組織具有完整的表皮與真皮構造,且沒有疤痕(scar)或組織沾黏(tissue adhesion)的情形產生,並擁有基底蛋白與分化蛋白的完整表現。 總結,利用冷凍乾燥與碳二醯胺交聯方式製備出的雙層孔洞結構之G-C6S-HA薄膜,具備有良好的型態,物理化學性質,以及生物相容性;在動物活體(in vivo)實驗上亦證明其具有促進傷口修復與良好的可吸收性(graft take)。未來此雙層孔洞結構之G-C6S-HA薄膜除了可當作支架,應用在組織工程上外;此人工皮膚替代物亦極具有潛力,應用在治療大面積燒燙傷與傷口難以癒合的病患身上,造福人群。 | zh_TW |
dc.description.abstract | In the study, the gelatin-chondroitin 6 sulfate-hyaluronic acid (G-C6S-HA) membrane was designed and fabricated as the scaffold to mimic the skin extracellular matrix in composition for skin tissue engineering. The bi-layer G-C6S-HA membrane with different pore sizes on each layer was prepared using freeze-drying technique. The biological stability of the membrane was improved by 1-ethyl-3 (3-dimethylaminopropyl) carbodiimide cross-linking process. The morphology, physical-chemical properties, and biocompatibility of the bi-layer G-C6S-HA membrane were evaluated to ensure bi-layer G-C6S-HA membrane applicable as a potential model for skin tissue engineering.
To reconstruct the skin equivalent, dermal fibroblasts were dynamically inoculated by self-designed spinner flask for optimizing homogeneous cell distribution in the G-C6S-HA membrane. After seeding with epidermal keratinocytes, the skin equivalent was cultured in submerged condition followed by transferring to air-liquid interface for epidermalization. Three weeks later, the keratinocytes differentiated into an epidermis-like structure with suprabasal layers and cornified squamous layer. The lower part of the membrane has developed into a dermis-like structure with sparse cell distribution surrounding with newly synthesized extracellular matrix. Next, this reconstructed skin equivalent was adopted to investigate the phenotypic and molecular expression of basement membrane (BM) and extracellular matrix (ECM) proteins in vitro. The deposition of BM and ECM proteins secreted by keratinocytes and dermal fibroblasts was quantitatively characterized by real-time PCR and examined by immunohistochemistry. The dynamics of RNA expression and protein deposition indicated a gradual synthesis pattern and assembly of the different constituents in a sophisticated and tightly regulated epithelial-mesenchymal interplay. Lastly, G-C6S-HA membrane was seeded with keratinocytes and dermal fibroblasts; then grafted onto the dorsum of SCID mice to evaluate the effect on promoting wound healing process. Four weeks after transplantation, the regenerated skin exhibited a well-developed epidermis and dermis that expressed the differentiated markers and the specific basement membrane proteins. The bi-layer G-C6S-HA skin substitute not only had positive effect on promoting wound healing process, but also revealed high percentage of graft take rate. To sum up, it is suggested that this newly designed bi-layer G-C6S-HA membrane is valuable as a skin substitute and possess great potential in the treatment of clinical patients with extensive burns and chronic wounds in the future. | en |
dc.description.provenance | Made available in DSpace on 2021-06-13T04:40:15Z (GMT). No. of bitstreams: 1 ntu-95-F90548046-1.pdf: 4259017 bytes, checksum: 21b422ea411fe34df3a62d35db8431c8 (MD5) Previous issue date: 2006 | en |
dc.description.tableofcontents | CONTENTS
Chapter 1 INTRODUCTION 1.1 Background Information-1 1.1.1 Gelatin and Glycosaminoglycans-1 1.1.2 1-ethyl-3(3-dimethylaminopropyl) Carbodiimide-3 1.1.3 Basement Membrane and Extracellular Matrix Proteins-4 1.2 Statement of the Problem-6 1.3 The Objective of This Study-8 Chapter 2 LITERATURE REVIEW 2.1 Anatomy of Skin-9 2.2 Structure and Function of Skin-10 2.2.1 Morphology and Function of the Dermis-11 2.2.2 Morphology and Function of the Epidermis-12 2.2.3 Morphology and Function of Basement Membrane-14 2.3 Burn Incidence in the USA and Taiwan-15 2.3.1 The Epidemiology of Hospitalized Burns Patients in the US-15 2.3.2 The Epidemiology of Hospitalized Burns Patients in Taiwan-15 2.4 Classification of Burn Injuries-16 2.5 Wound Healing Process-18 2.6 Treatment of Large Wound Defects-21 2.6.1 Wound Coverage with Xenogeneic Grafts-21 2.6.2 Wound Coverage with Allogeneic Grafts-22 2.6.3 Skin Replacement with Autologous Grafts-23 2.7 Tissue-engineered Skin Substitute -25 2.7.1 Significance of Artificial Skin-25 2.7.2 Commercialized Artificial Skin Products -27 Chapter 3 THEORETICAL BASIS 3.1 The Tissue Engineering Approach-33 3.1.1 Cell Expansion-33 3.1.2 Three-Dimensional Tissue Culture-33 3.1.3 Bioreactors as Organ Support Devices-33 3.2 The Strategies for Re-construction of Skin Tissue-34 Chapter 4 MATERIALS AND METHODS 4.1 Evaluation and Biological Characterization of Bi-layer Gelatin-Chondroitin 6 Sulfate-Hyaluronic Acid Membrane-35 4.1.1 Preparation of Cross-linked Bi-layer G-C6S-HA Membrane-35 4.1.2 Fourier-transformed Infrared (FT-IR) Spectra Measurement-36 4.1.3 Glycosaminoglycan Contents in Cross-linked G-C6S-HA Membrane-36 4.1.4 In Vitro Degradation of Cross-linked G-C6S-HA Membrane-37 4.1.5 Water Absorption Ability-37 4.1.6 Morphology of Bi-layer G-C6S-HA Membrane-38 4.1.7 Culture of Keratinocytes and Dermal Fibroblasts-39 4.1.8 Matrix Biocompatibility Test-40 4.1.8-1 MTT Test-40 4.1.8-2 LDH Assay-40 4.1.8-3 Cell-Matrix Interaction-41 4.1.9 Statistical Analysis-41 4.2 Biomimetic Bi-layer Gelatin-Chondroitin 6 Sulfate-Hyaluronic Acid Biopolymer as a Scaffold for Skin Equivalent Tissue Engineering-42 4.2.1 Preparation of Porous Bi-layer G-C6S-HA Membrane-42 4.2.2 Culture of Keratinocytes and Dermal Fibroblasts-42 4.2.3 Skin Equivalent Preparation-42 4.2.4 Colorimetric MTT (Tetrazolium) Assay for Cell Viability-43 4.2.5 Total DNA Analysis for Quantification of Cell Growth-44 4.2.6 Scanning Electron Microscope (SEM) for Cell Morphology-44 4.2.7 Histology and Immunohistochemistry-45 4.3 Skin Basement Membrane and Extracellular Matrix Proteins Characterization and Quantification by Real-time PCR-46 4.3.1 Preparation of Porous Bi-layer G-C6S-HA Membrane-46 4.3.2 Culture of Keratinocytes and Dermal Fibroblasts-46 4.3.3 Reconstruction of Skin Equivalents-46 4.3.4 Total RNA Extraction-47 4.3.5 Quantitative Reverse Transcription- PCR-48 4.3.6 Immunohistochemistry-50 4.3.7 Statistical Analysis-50 4.4 Wound Healing Effect of Reconstructed Skin Equivalent in SCID Mice-51 4.4.1 Preparation of Bi-layer G-C6S-HA Scaffold-51 4.4.2 Culture of Keratinocytes and Dermal Fibroblasts-51 4.4.3 Skin Equivalent Preparation-51 4.4.4 Grafting of Bi-layer G-C6S-HA Skin Equivalent-52 4.4.5 Histology and Immunohistochemistry Analysis-53 4.4.6 Cytogenetic Analysis-54 Chapter 5 RESULTS 5.1 Physical-chemical Characteristics of Bi-layer G-C6S-HA Membrane-55 5.1.1 IR Measurement-55 5.1.2 Glycosaminoglycan Content-56 5.1.3 Determination of Degradation Rate-58 5.1.4 Water Absorption Ability-59 5.1.5 Morphology of Bi-layer G-C6S-HA Membrane-60 5.1.6 Biocompatibility of Bi-layer G-C6S-HA Membrane-62 5.1.6-1 Cell Viability-- MTT Test-62 5.1.6-2 Cell Cytotoxicity-- LDH Test-63 5.1.6-3 Attachment and Proliferation of Keratinocytes and Dermal Fibroblasts on the G-C6S-HA Membrane-64 5.2 Biomimetic G-C6S-HA Membrane as a Scaffold for Skin Tissue Engineering-65 5.2.1 Dermal Fibroblasts Seeding, Migration, and Proliferation-65 5.2.2 The Attachment, Proliferation, and Differentiation of Keratinocytes-67 5.2.3 Skin Equivalent Development-69 5.3 Skin Proteins Characterization and Quantification-71 5.3.1 Expression of BM and ECM Proteins-71 5.3.2 delta CT of BM and ECM Proteins-73 5.3.3 -delta delta CT of BM and ECM Proteins-75 5.3.4 Gel Electrophoresis-78 5.3.5 Immunohistochemistry Stain for the Cultured Skin Equivalents-80 5.4 Wound Healing Effect of Reconstructed Skin Equivalent in SCID Mice-83 5.4.1 Macroscopic Observation-83 5.4.2 Take Percentages in the Full-thickness Skin Defect after Transplantation-87 5.4.3 Wound Healing Process-88 5.4.4 Identification of the Origin of Newly Synthesized Skin Tissue-89 5.4.5 Histology Examination of Skin Morphology-90 5.4.6 Immunohistochemistry Analysis-92 5.4.7 Basement Membrane Zone Reconstruction-94 Chapter 6 DISCUSSION 6.1 Evaluation and Biological Characterization of Bi-layer Gelatin-Chondroitin 6 Sulfate-Hyaluronic Acid Membrane-96 6.2 Biomimetic Bi-layer Gelatin-Chondroitin 6 Sulfate-Hyaluronic Acid Biopolymer as a Scaffold for Skin Equivalent Tissue Engineering-99 6.3 Skin Basement Membrane and Extracellular Matrix Proteins Characterization and Quantification by Real-time PCR-102 6.4 Wound Healing Effect of Reconstructed Skin Equivalent in SCID Mice-105 Chapter 7 CONCLUSION-108 Chapter 8 FUTURE PERSPECTIVE-110 8.1 Animal Models-110 8.2 Relative Regenerative Factors-110 8.3 The Long Term Goal-110 REFERENCE-111 APPENDIX-123 | |
dc.language.iso | en | |
dc.title | 以角質細胞及真皮纖維母細胞共養於雙層孔洞結構之明膠/葡萄胺聚醣基材作為皮膚組織工程之研究 | zh_TW |
dc.title | Keratinocytes and Dermal Fibroblasts Coculture on a Bi-layer Gelatin/Chondoitin-6-Sulfate/Hyaluronic Acid Membrane as a Model of Skin Tissue Engineering | en |
dc.type | Thesis | |
dc.date.schoolyear | 94-2 | |
dc.description.degree | 博士 | |
dc.contributor.coadvisor | 孫瑞昇(Jui-Sheng Sun) | |
dc.contributor.oralexamcommittee | 余幸司,陳耀昌,王盈錦,宋信文,陳克紹,曾厚,陳天牧 | |
dc.subject.keyword | 明膠,軟骨硫素,透明質酸,角化細胞,真皮纖維母細胞,基底層,皮膚組織工程, | zh_TW |
dc.subject.keyword | gelatin,chondroitin-6-sulfate,hyaluronic acid,keratinocyte,dermal fibroblast,basement membrane,wound healing,skin tissue engineering, | en |
dc.relation.page | 124 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2006-07-19 | |
dc.contributor.author-college | 工學院 | zh_TW |
dc.contributor.author-dept | 醫學工程學研究所 | zh_TW |
Appears in Collections: | 醫學工程學研究所 |
Files in This Item:
File | Size | Format | |
---|---|---|---|
ntu-95-1.pdf Restricted Access | 4.16 MB | Adobe PDF |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.